Advertisements


Aimmune briefing doc contains no big surprises, Feuerstein says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Piper says FDA briefing docs remove key underpinning of Aimmune bear thesis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Aimmune briefing docs look "pretty benign," says Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Aimmune jumps 9% to $23.95 after FDA posts briefing docs for panel meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

FDA posts briefing docs for Aimmune panel, brings up allergic reactions

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Analyst: DBV"s Peanut Allergy Drug Could Outscore Aimmune"s On Safety Front

Aimmune Therapeutics Inc (NASDAQ: AIMT)'s peanut allergy product candidate Palforzia to treat peanut allergy in children and adolescents has received .....»»

Category: blogSource: benzinga17 hr. 15 min. ago

Aimmune says "in the middle" of working on pricing for Palforzia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 15 min. ago

Good News, Bad News in the War on Peanut Allergy

Aimmune shares dipped on Monday after the FDA's Allergenic Products Advisory Committee voted to support the use of AR101 (Palforzia) in children and teens with peanut allergy......»»

Category: blogSource: 247wallst22 hr. 45 min. ago

Peninsula drug company takes big step toward peanut allergy drug approval

Aimmune Therapeutics Inc.'s quest to sell the first biologic drug to treat peanut allergies won a regulatory advisory committee's blessing Friday, moving the company closer to Food and Drug Administration approval. The action by the nine-member panel do.....»»

Category: topSource: bizjournalsSep 16th, 2019

Aimmune Therapeutics stock price target raised to $30 from $24 at Stifel Nicolaus

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 16th, 2019

Top Analyst Upgrades and Downgrades: Aimmune, Apple, Aurora Cannabis, Dick’s, Halliburton, HP, JPMorgan, Lowe’s, Lyft, Schlumberger, Uber and More

The top analyst upgrades, downgrades and initiations for Monday included Aimmune Therapeutics, Apple, Aurora Cannabis, Dick's Sporting Goods, Halliburton, HP, JPMorgan, Lowe's, Lyft, Schlumberger and........»»

Category: blogSource: 247wallstSep 16th, 2019

Aimmune panel meeting holds "three key positives" for DBV, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

APAC vote increases Aimmune Palforzia odds of approval, says Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

H.C. Wainwright reiterates Buy on DBV Technologies after Aimmune panel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

Wedbush anticipates approval of Aimmune"s Palforzia in January 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

Aimmune price target raised to $30 after "positive" FDA panel at Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 16th, 2019

Continued Upside Surprises In Store For Jinko Solar

Continued Upside Surprises In Store For Jinko Solar.....»»

Category: topSource: seekingalphaSep 15th, 2019

Editor"s briefing: How Hallmarket illustrates the best of KC"s business culture [PHOTOS]

Kansas City Business Journal Associate Editor Andrew Vaupel takes a swing at this week's "Editor's briefing," as Editor Brian Kaberline prepares for a well-deserved week off. Next to Sprint Corp., Hallmark Cards Inc. may be the biggest household name to.....»»

Category: topSource: bizjournalsSep 15th, 2019

DBV Technologies falls 2% after FDA panel votes in favor of Aimmune drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2019

FDA committee votes to support use of Aimmune"s Palforzia for peanut allergy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2019

Aimmune"s AR101 prospects derisked by FDA panel decision, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2019